http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006514094-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-203
filingDate 2003-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2006514094-A
titleOfInvention Formulations useful for hepatitis C virus infection
abstract The present invention relates generally to compounds and chemicals that are effective against hepatitis C virus (HCV) infection. The present invention further includes compositions comprising said compounds and / or chemicals, methods for preventing HCV infection, and compounds for the preparation of compositions useful for the prevention and / or treatment of HCV infection and / or Regarding the use of chemical substances. Useful compounds and chemical entities of the present invention, the selenium, selenium salts, vitamin D 3 and retinoids, for example all-trans retinoic acid and its salts, C 1 -C 10 alkyl amides of all-trans retinoic acid and its salts, all trans retinoic C 1 -C 10 alkyl esters and their salts of acids, 9-cis retinoic acid and its salts, 9-cis C 1 -C 10 alkyl amides of retinoic acid and its salts, 9-cis C 1 -C 10 retinoic acid Alkyl esters and their salts, (E) -4- [2- (5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl-1-propenyl] benzoic acid (TTNPB) , (4- [5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carboxamide] benzoic acid (AM-580), N- (4-hydroxyphenyl) retinamide ( 4-HPR), and 6- [3- (1-adamantyl) -4-hydroxyphenyl] -2-naphthalenecarboxylic acid (AHPN).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014129364-A
priorityDate 2002-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02084294-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02066022-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226538493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226535571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5289501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410884

Total number of triples: 59.